admin – Page 2943 – Get News Story

Blue Sky Scrubs Marks 20 Years of Innovation, Offering the World’s Largest Range of Custom Scrub Caps from Austin

After Two Decades of Crafting Premium Medical Scrubs, Blue Sky Scrubs Continues to Lead the $13.8 Billion Medical Uniforms Market with Unmatched Quality, Style, and Healthcare Professional-First Design Philosophy.

AUSTIN, TX – June 18, 2025 – Blue Sky Scrubs, the Austin-based medical apparel innovator that has spent two decades perfecting the art of comfortable, stylish healthcare uniforms, today reinforces its position as the industry leader in premium medical scrubs and surgical caps. With thousands of unique designs across five distinct scrub cap styles and an ever-expanding collection of medical uniforms, Blue Sky Scrubs has transformed how healthcare professionals think about their work attire.

More information can be found at https://blueskyscrubs.com.

The Data That Drives Healthcare Fashion Forward

Here’s what makes this story remarkable: While the average medical professional spends over 40 hours per week in their scrubs, traditional medical uniforms have remained largely unchanged for decades. Blue Sky Scrubs identified this massive gap in the market and has systematically addressed every pain point healthcare workers face with their work attire.

The numbers tell the story:

20 years of continuous innovation and refinement
Thousands of unique scrub cap designs available daily
Five distinct scrub cap styles to match every preference
100% cotton construction for maximum comfort and durability
Daily additions to their pattern library, making it the world’s largest selection

The Blue Sky Difference: Why Healthcare Professionals Are Making the Switch

Premium Materials Meet Practical Design

Unlike mass-produced medical uniforms that prioritize cost over comfort, Blue Sky Scrubs constructs every piece from high-quality materials specifically chosen for healthcare environments. Their signature 100% cotton twill lab coats provide the perfect balance of professional appearance and practical functionality, featuring multiple pockets for essential tools while maintaining breathability during long shifts.

The Austin Advantage

Founded in the vibrant creative hub of Austin, Texas, Blue Sky Scrubs brings a unique perspective to medical fashion. The company’s “relaxed vibes” philosophy translates into scrubs that healthcare professionals actually want to wear, not just have to wear.

“We’ve spent 20 years perfecting our craft because we understand that comfortable healthcare workers provide better patient care,” explains the Blue Sky Scrubs team. “Every stitch, every fabric choice, every design decision is made with the healthcare professional in mind.”

Market Disruption Through Innovation

Breaking the Mold of Traditional Medical Uniforms

The medical uniform industry has historically operated on a one-size-fits-all mentality, but Blue Sky Scrubs recognized that healthcare professionals are individuals with unique style preferences and functional needs. Their comprehensive approach addresses every aspect of medical apparel:

Women’s Medical Scrubs Collection:

Stretch and non-stretch options for different comfort preferences
Classic and embellished designs to match personal style
Ultra-soft fabric technology that maintains durability
Perfectly balanced jogger and straight-leg scrub pants
Coordinated scrub tops designed for optimal movement and comfort

Men’s Medical Scrubs Innovation:

Elevated, refined designs that maintain professionalism
High-quality fabric construction with exceptional craftsmanship
Well-tailored fits that provide comfort without sacrificing appearance
Classic color options including navy, black, ceil blue, and grey
Attention to detail that sets Blue Sky apart from generic alternatives

The Science of Scrub Cap Perfection

Perhaps nowhere is Blue Sky Scrubs’ innovation more evident than in their scrub cap collection. With the world’s largest selection of medical scrub caps, they’ve turned what was once a purely functional item into a form of professional self-expression.

Technical Specifications That Matter:

100% cotton construction for breathability and comfort
Designs that accommodate all-day wear without discomfort
Novelty fabrics that allow healthcare professionals to express personality
Professional options including pinstripe and plaid for refined appearances
Daily pattern additions ensuring fresh options are always available

Beyond Products: Building a Healthcare Lifestyle Brand

The Blue Sky Scrubs Ecosystem

Blue Sky Scrubs has evolved beyond a simple medical uniform supplier into a comprehensive healthcare lifestyle brand. Their product ecosystem includes:

Complete Layering Solutions:

Base layers that add warmth without bulk or bunching
Lightweight to heavy outerwear options for all seasons
Scrub jackets designed for professional layering
Vests and specialty outerwear for diverse medical environments

Professional Laboratory Wear:

Premium lab coats with strategic pocket placement
Side openings for easy access to scrub pant pockets
Fabric thickness optimized for opacity without excess weight
Professional white fabric that maintains crisp appearance

The Customer-Centric Approach That Drives Growth

Understanding Healthcare Professional Needs

Blue Sky Scrubs’ success stems from their deep understanding of healthcare professional challenges. Long shifts, physical demands, patient interaction requirements, and professional appearance standards all factor into their design process.

Key Differentiators:

Athletic-inspired comfort technology
Hand-made attention to detail
Continuous innovation based on user feedback
Superior fabric selection and testing
Professional styling that doesn’t sacrifice comfort

Market Position and Industry Recognition

Leading the $13.8 Billion Medical Uniforms Market

The global medical uniforms market continues expanding as healthcare employment grows and quality expectations rise. Blue Sky Scrubs has positioned itself at the premium end of this market, focusing on healthcare professionals who understand that their uniform impacts both their comfort and their professional confidence.

Competitive Advantages:

Unmatched product variety and customization options
Superior material quality and construction standards
Innovative design philosophy rooted in actual healthcare professional needs
Continuous product development and pattern expansion
Strong brand loyalty among healthcare professionals

Sustainability and Ethical Manufacturing

Responsible Production Practices

Blue Sky Scrubs maintains high standards not just in product quality but in production ethics. Their commitment to hand-made craftsmanship supports skilled textile workers while ensuring each piece meets their exacting quality standards.

Quality That Endures:

Durable construction that withstands frequent washing and intensive use
Stain-resistant fabrics that maintain professional appearance
Color-fast materials that retain vibrancy through repeated laundering
Reinforced stress points for extended wear life

The Future of Medical Fashion

Innovation Pipeline and Market Expansion

With 20 years of experience and continuous innovation, Blue Sky Scrubs shows no signs of slowing down. Their daily addition of new patterns and ongoing development of improved materials and construction techniques positions them for continued market leadership.

Looking Forward:

Expanded product lines addressing emerging healthcare professional needs
Enhanced fabric technologies for improved comfort and performance
Continued growth in custom and specialty medical apparel
International expansion opportunities in growing healthcare markets

About Blue Sky Scrubs

Founded in Austin, Texas, Blue Sky Scrubs has spent two decades perfecting the art of medical apparel design and manufacturing. Specializing in premium scrubs, surgical caps, and medical uniforms, the company serves healthcare professionals who demand both style and functionality from their work attire. With the world’s largest selection of scrub caps and a comprehensive collection of medical uniforms for both men and women, Blue Sky Scrubs continues to set industry standards for quality, comfort, and professional appearance.

For more information about Blue Sky Scrubs and their complete collection of medical apparel, visit https://blueskyscrubs.com or contact:

Blue Sky Co. 2209 Donley Dr Austin, TX 78758

Phone: (888) 302-5837

International: +1 (720) 408-1124

Email: info@blueskyscrubs.com

Media Contact
Company Name: Blue Sky Scrubs
Email: Send Email
Phone: (888) 302-5837
Address:Blue Sky Co 2209 Donley Dr
City: Austin
State: Texas
Country: United States
Website: https://blueskyscrubs.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blue Sky Scrubs Marks 20 Years of Innovation, Offering the World’s Largest Range of Custom Scrub Caps from Austin

Revolutionary Window Repair Technology Saves Ottawa Homeowners Up to 70% on Replacement Costs

Local Window Restoration Company Introduces Game-Changing Defogging Solutions That Extend Window Life by 20 Years.

OTTAWA, ON – June 18, 2025 – Ottawa Window Medics, the region’s leading window and door restoration specialist, is transforming how homeowners approach foggy window problems with breakthrough defogging technology that delivers results traditional replacement companies simply can’t match.

Here’s the shocking truth most window companies won’t tell you: 95% of “unfixable” foggy windows can actually be restored to like-new condition – saving homeowners thousands of dollars in unnecessary replacement costs.

The $4.2 Billion Problem Hidden in Plain Sight

Every year, Canadian homeowners spend over $4.2 billion replacing windows that could have been repaired for a fraction of the cost. The reason? Most window companies only offer one solution: complete replacement.

“We discovered that 9 out of 10 homeowners we surveyed believed window fogging was irreversible,” says the technical team at Ottawa Window Medics. “The reality is that with the right expertise and technology, these windows can be restored to their original clarity and given another 20 years of life.”

The Science Behind the Solution

Window fogging occurs through a process called “solar pumping” – a phenomenon that affects virtually every double and triple-pane window in Canada. Here’s exactly what happens:

Daytime Heating: Sunlight heats window panes, building pressure between glass layers
Air Expulsion: Tiny amounts of air escape as pressure increases
Evening Cooling: Windows cool down, creating negative pressure
Moisture Infiltration: Outside air containing moisture gets drawn back in
Saturation Point: Silica desiccant becomes overwhelmed, leading to permanent fogging

Traditional window companies treat this as terminal window failure. Ottawa Window Medics treats it as a completely solvable engineering problem.

The 70% Cost Savings Breakthrough

Ottawa Window Medics’ proprietary restoration process delivers results that seem almost too good to be true:

50-70% cost savings compared to full window replacement
20-year extended lifespan for restored windows
Same-day service available for most repairs
Lifetime warranty on defogging services

“Last month alone, we saved Ottawa homeowners over $180,000 in unnecessary replacement costs,” reports the company’s service team. “One client was quoted $8,500 for window replacements. We restored all 12 windows for $2,400 – and they look absolutely perfect.”

Beyond Defogging: A Complete Window Ecosystem

While defogging remains their signature service, Ottawa Window Medics has evolved into a comprehensive window and door solution provider:

Glass Replacement Services:

Single, double, and triple-pane glass restoration
Tempered and safety glass installation
Self-cleaning glass technology
Custom shower enclosures

Complete Window Solutions:

Energy Star-rated vinyl windows
CSA-certified installations
25% savings on new window projects
Full range: Casement, Double-Hung, Bay, Bow, Slider configurations

Door Expertise:

Nearly 100 exterior door designs
Sliding patio door specialists
Professional installation services
Hinge repair and hardware restoration

The Ottawa Advantage: Why Location Matters

Ottawa’s unique climate creates specific challenges for window performance. The city’s temperature fluctuations – from -30°C winters to +35°C summers – accelerate the solar pumping process that causes window seal failures.

“We’ve calibrated our restoration techniques specifically for Ottawa’s climate conditions,” explains the technical team. “Windows restored using our process actually perform better in extreme temperature swings than many new installations.”

Real Results from Real Ottawa Homeowners

The numbers speak for themselves:

2,847 windows successfully defogged in 2024
94.3% customer satisfaction rating
Average savings of $4,200 per household
Zero callback rate on warranty work

Sarah M., Kanata resident: “I was devastated when condensation appeared in my living room windows. Three companies told me I needed full replacement costing $6,000. Window Medics fixed everything for $1,200, and six months later, they still look brand new.”

Michael T., Orleans homeowner: “The difference is incredible. My windows are clearer now than when I first bought the house. I can’t believe I almost spent $10,000 on replacements.”

The Technology Behind the Magic

Ottawa Window Medics’ success stems from proprietary technology that addresses window restoration at the molecular level:

Advanced Moisture Extraction: Custom-designed equipment removes 100% of trapped moisture without damaging window seals.

Desiccant Regeneration: Specialized process restores silica desiccant to original absorption capacity.

Seal Reinforcement: Micro-coating technology strengthens existing seals against future moisture infiltration.

Quality Assurance Testing: Every restored window undergoes pressure testing to ensure 20-year performance standards.

Environmental Impact: The Sustainability Story

Window replacement creates significant environmental waste. A typical Ottawa home window replacement project generates:

450 pounds of landfill waste
2.3 tons of CO2 emissions from manufacturing
$800-1,200 in disposal costs

Window restoration eliminates 95% of this environmental impact while delivering superior cost savings.

“We’re not just saving homeowners money,” notes the company’s sustainability coordinator. “We’re preventing thousands of pounds of perfectly good materials from entering landfills every month.”

The Competitive Landscape: Why Others Can’t Compete

Most window companies operate on a replacement-first business model because:

Limited Technical Expertise: Restoration requires specialized training most companies lack
Equipment Investment: Professional defogging equipment costs $50,000-75,000 per unit
Warranty Concerns: Companies fear liability on restoration work
Profit Margins: Replacement projects generate higher short-term profits

Ottawa Window Medics invests heavily in:

Continuous technical training for all technicians
State-of-the-art equipment updated annually
Comprehensive warranty programs backed by proven results
Long-term customer relationships over short-term profits

Service Area Expansion Plans

Currently serving Ottawa and surrounding areas including:

Kanata and Stittsville
Orleans and Cumberland
Nepean and Barrhaven
Gloucester and Vanier
Gatineau and Chelsea

Plans for 2025 include expansion into:

Kingston and surrounding area
Brockville and Prescott
Cornwall and Alexandria
Pembroke and Petawawa

The 20-Year Window Performance Guarantee

Ottawa Window Medics stands behind their work with the industry’s most comprehensive warranty:

20-year performance guarantee on all defogging work
Lifetime warranty on glass replacement
5-year full coverage on new window installations
24/7 emergency service for urgent repairs

How to Access These Services

Getting started is remarkably simple:

Free Consultation: Call 613-519-1317 for immediate scheduling No-Obligation Quote: On-site assessment with transparent pricing Same-Day Service: Most repairs completed within 24 hours Flexible Payment: Multiple payment options available

Email Contact: info@windowmedics.com Service Request: Online form at ottawa.windowmedics.com

Industry Recognition and Certifications

Ottawa Window Medics maintains:

Better Business Bureau A+ Rating
Energy Star Partnership certification
CSA Approved installation standards
WSIB Certified safety compliance
Fully Insured comprehensive coverage

The Bottom Line for Ottawa Homeowners

The window industry has trained homeowners to accept replacement as the only solution for common problems. Ottawa Window Medics proves this assumption wrong every single day.

With proven technology, comprehensive warranties, and dramatic cost savings, window restoration isn’t just an alternative to replacement – it’s often the superior choice.

The next step is simple: Call 613-519-1317 today for a free consultation. Discover why thousands of Ottawa homeowners are choosing restoration over replacement.

About Ottawa Window Medics

Founded in 2004, Ottawa Window Medics specializes in advanced window and door restoration services throughout the National Capital Region. The company’s mission is to provide cost-effective, environmentally responsible solutions that extend the life of existing windows while delivering superior performance. Located at 310-900 Greenbank Road, Ottawa, ON K2J 4P6.

Media Contact:

Ottawa Window Medics

Phone: 613-519-1317

Email: info@windowmedics.com

Website: ottawa.windowmedics.com

Window Medics Inc. – Your One-Stop Window Shop

Media Contact
Company Name: Window Medics
Email: Send Email
Phone: 613-519-1317
Address:900 Greenbank Rd Nepean
City: Ottawa
Country: Canada
Website: https://ottawa.windowmedics.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Revolutionary Window Repair Technology Saves Ottawa Homeowners Up to 70% on Replacement Costs

Systemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting-Edge Therapies | DelveInsight

The systemic lupus erythematosus (SLE) treatment pipeline is experiencing unprecedented expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, including Biogen, Idorsia Pharmaceuticals, AbbVie, BioSenic, Roche, Novartis, Allogene Therapeutics, Adicet Bio, and numerous other leading companies advancing innovative treatments through robust clinical development programs.

DelveInsight’s “Systemic Lupus Erythematosus Pipeline Insight, 2025” report delivers comprehensive insights about 120+ companies and 140+ pipeline drugs currently in the various systemic lupus erythematosus clinical trials stages. The report provides an in-depth understanding of the current treatment landscape, emerging therapies, and key systemic lupus erythematosus companies, offering crucial insights for stakeholders in the evolving systemic lupus erythematosus therapeutic landscape.

Stay ahead with the latest clinical developments, emerging therapies, and strategic opportunities in this rapidly evolving landscape @ Systemic Lupus Erythematosus Clinical Trials

Systemic lupus erythematosus is a complex autoimmune disease marked by dysregulated immune responses, multi-organ inflammation, and unpredictable disease flares. Despite advances in standard-of-care therapies, significant unmet needs persist, including durable disease remission, organ protection, and tailored treatments for diverse patient subpopulations. As SLE affects predominantly women of childbearing age and shows higher prevalence in certain ethnic groups, personalized medicine approaches have become critical for optimizing patient outcomes.

According to DelveInsight’s analysis, the systemic lupus erythematosus treatment pipeline has entered a new era of innovation, driven by breakthrough mechanisms, regulatory designations, and robust clinical programs from leading biopharmaceutical companies.

DelveInsight report provides therapeutic assessment segregated by various parameters, including clinical trial phase, route of administration (oral, intravenous, subcutaneous, parenteral, topical), and molecule type (recombinant fusion proteins, small molecules, monoclonal antibodies, peptides, polymers, gene therapy). This comprehensive categorization enables stakeholders to understand the diverse therapeutic approaches being pursued.

See how leading biopharma companies are addressing unmet needs and driving market growth through precision medicine and targeted approaches @ Systemic Lupus Erythematosus Companies

BIIB059 (Litifilimab) is a humanized IgG1 monoclonal antibody developed by Biogen and is in phase III. This therapy specifically targets BDCA2 on plasmacytoid dendritic cells and is intended for treating moderate-to-severe systemic lupus erythematosus. Additionally, Cenerimod is an oral selective S1P1 modulator from Idorsia Pharmaceuticals. It aims to reduce circulating lymphocytes and is in pivotal Phase III development to improve disease control and decrease SLE flares.

RINVOQ, a fixed-dose combination therapy from AbbVie comprising the Bruton’s tyrosine kinase inhibitor elsubrutinib and the Janus kinase inhibitor upadacitinib, is exploring synergistic immune modulation in SLE and other autoimmune indications in Phase III studies, with results anticipated in 2026. Arscimed, developed by BioSenic, utilizes arsenic trioxide to target upstream immune activation and is also under Phase II evaluation for refractory SLE, addressing root pathogenic cascades. Furthermore, Mosunetuzumab, a bispecific antibody by Roche that engages CD20 on B cells and CD3 on T cells, is advancing through Phase I trials in SLE by redirecting T-cell cytotoxicity against autoreactive B cells.

These lupus pipeline therapies underscore the emerging trends within the forecast period, with the next generation of targeted therapies addressing the complex pathophysiology of systemic lupus erythematosus.

Adicet Bio achieved significant regulatory milestones in 2025 with its allogeneic gamma delta CAR-T cell therapy ADI-001 receiving multiple FDA Fast Track designations in February 2025 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement. This followed an earlier Fast Track designation granted in June 2024 for relapsed/refractory class III or class IV lupus nephritis.

The dual Fast Track designations underscore the urgent need for new therapies in lupus, particularly for patients with refractory disease. ADI-001 targets CD20 and is currently being evaluated in a Phase 1 clinical trial across six autoimmune indications, including SLE, systemic sclerosis, and idiopathic inflammatory myopathy

Furthermore, Allogene Therapeutics announced in April 2025 that their investigational dual-targeted CD19/CD70 allogeneic CAR-T therapy ALLO-329 received three Fast Track designations from the FDA for the treatment of adult patients with autoimmune diseases.

In April 2025, Calibr-Skaggs Institute received FDA clearance for its investigational new drug application to study switchable CAR-T therapy (CLBR001 + SWI019) in patients with autoimmune conditions.

In March 2025, the FDA accepted Roche’s supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva/Gazyvaro) for the treatment of lupus nephritis, with a decision on approval expected by October 2025.

These recent developments highlight the major emerging trends in this autoimmune disease treatment landscape, including chimeric antigen receptor T-cell (CAR-T) therapy, small molecule treatments for lupus, CAR-NK therapy for lupus, and combined impediment of human plasmacytoid dendritic cell activity.

Discover more recent advancements in the Systemic Lupus Erythematosus treatment landscape @ Systemic Lupus Erythematosus Recent Developments.

Looking ahead, the systemic lupus erythematosus pipeline is expected to witness continued innovation driven by enhanced understanding of disease mechanisms, biomarker development, and a highly competitive landscape. While significant progress has been made with targeted immunotherapies, challenges remain in addressing complete disease remission, preventing flares, and improving treatment accessibility across diverse patient populations. As research continues and awareness grows, the systemic lupus erythematosus pipeline is poised for remarkable expansion and therapeutic innovation.

Table of Contents

1. Introduction

2. Executive Summary

3. Systemic Lupus Erythematosus Overview

4. Pipeline Therapeutics

5. Comparative Analysis

6. Therapeutic Assessment

7. Systemic Lupus Erythematosus – DelveInsight’s Analytical Perspective

8. Late Stage Products (Phase III)

9. Mid-Stage Products (Phase II)

10. Early Stage Products (Phase I)

11. Preclinical and Discovery Stage Products

12. Inactive Products

13. Comparative Analysis

14. Systemic Lupus Erythematosus Collaborations Assessment

15. Systemic Lupus Erythematosus Unmet Needs

16. Systemic Lupus Erythematosus Market Drivers and Barriers

17. Appendix

The Systemic Lupus Erythematosus Treatment Market report offers comprehensive insights into the systemic lupus erythematosus market outlook, including historical and projected epidemiological data, along with market trends across the 7MM

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Systemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting-Edge Therapies | DelveInsight

Precision Air Discusses HVAC Industry Hot Topics Including New Refrigerant and Tariffs

Heating and cooling prices are on the rise, and a new refrigerant is replacing the old style refrigerant in cooling systems

JUNE 18, 2025 – This summer, consumers are facing higher prices when it comes to their HVAC systems. Precision Air, a trusted heating and cooling service provider serving businesses and residences across Washington and Oregon, has released a statement discussing some of the hottest topics in the industry right now.

Due to EPA mandates, this year marks the rollout of a requirement to shift from refrigerant R-410A to options such as R-32 and R-454B. These options are considered to have lower Global Warming Potential (GWP). The American Innovation and Manufacturing (AIM) Act has caused the EPA to release this guidance, with the required shift happening this year. “This shift is making a mark on the industry because the new refrigerant options are more costly. The good news is that R-32 is considerably more efficient, and you can anticipate that you’ll have fewer refrigerant charges,” said the team at Precision Air.

Secondly, Precision Air is addressing energy cost spikes that are anticipated in response to the tariffs put into place by the current administration. “Summer utility bills are likely to reach 12-year highs,” said the team at Precision Air.

Current estimates indicate that the price of heating and cooling systems could increase by up to 30% due to tariffs on materials such as aluminum, steels, and electronic components that are utilized in HVAC manufacturing here in the U.S.

Precision Air has some advice for consumers. “Do all the things you’d normally do to conserve energy this summer. Keep your thermostat set at a responsible temperature, and only run your electronics when you need to. If your HVAC needs maintenance or repairs, you’ll want to go ahead and schedule now before the prices go any higher,” said a spokesperson for Precision Air.

Precision Air was founded in 2017 in Portland, Oregon. In 2017, the company merged with Washougal Heating, which was established in 1952 in Vancouver, Washington. Now, Precision Air proudly serves both areas with full-service solutions for AC and heating repairs, maintenance, and new installs. The company’s team works alongside clients to find the right system for their new installation, including top heating and air conditioning products. Maintenance plans are available to help clients keep their systems running optimally all year long, and financing plans make it easier than ever to get a world-class system installed.

Further information about Precision Air can be found by visiting precisionaircompany.com.

ABOUT PRECISION AIR

With offices in Washington and Oregon, Precision Air offers trusted, professional heating and cooling services for businesses and residences.

Media Contact
Company Name: Precision Air
Contact Person: Paul Vynar
Email: Send Email
Phone: (360) 787-1600
Address:5305 NE 121st Ave #102
City: Vancouver
State: WA 98682
Country: United States
Website: https://precisionaircompany.com/

Celiac Disease Treatment Market Set for Robust Growth Through 2034, Driven by Recent Developments in Clinical Development Pipeline | DelveInsight

“Celiac Disease Market Insight, Epidemiology And Market Forecast”

The celiac disease treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, including Entero Therapeutics, Amgen/Provention Bio, Takeda, and Sanofi, among others.

DelveInsight’s “Celiac Disease Market Insight, Epidemiology And Market Forecast – 2034” report delivers an in-depth understanding of the celiac disease treatment market, historical and forecasted epidemiology, as well as market trends across the US, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report comprehensively evaluates the current treatment landscape, emerging therapies, market share of individual treatments, and celiac disease market forecasts through 2034, providing crucial insights for stakeholders in the celiac disease therapeutic area.

According to DelveInsight’s analysis, the United States held the largest share of the celiac disease drugs market in 2023, accounting for approximately 70% of the total market across 7MM. The market in Japan was valued at approximately USD 1.5 billion, demonstrating significant regional market potential. The celiac disease market is set for notable growth, fueled by rising awareness, better diagnostics, and increasing celiac disease prevalence.

The market expansion is further driven by enhanced understanding of celiac disease mechanisms, patient-centric therapeutic trial approaches, and the urgent need for advanced treatment options beyond traditional gluten-free diet management.

Download the Celiac Disease Market report to understand which factors drive the Celiac Disease market @ Celiac Disease Market Trends.

Celiac disease is an autoimmune disorder where ingestion of gluten triggers an immune response that damages the small intestine’s lining. It affects approximately 1 in 100 people worldwide, yet only about 30% are properly diagnosed. The disease predominantly impacts females and is most commonly diagnosed in individuals aged 19-39, emphasizing the need for timely detection and management. In Germany, approximately 60% of diagnosed cases are female, highlighting the gender-specific prevalence patterns across different regions.

The DelveInsight report categorizes the celiac disease patient population into several main groups for analysis, including total prevalent population, total diagnosed prevalent population, gender-specific cases, age-specific cases, and type-specific prevalent population. In 2023, classical celiac disease comprised about 30% of all celiac disease cases in Japan, demonstrating regional variations in disease presentation. This classification is essential for understanding the distribution, progression, and treatment responses of different celiac disease types, which is crucial for accurate epidemiological assessment.

Discover evolving trends in the Celiac Disease patient pool forecasts @ Celiac Disease Epidemiology Analysis.

The DelveInsight report further analyses the current and emerging celiac disease treatment landscape. Currently, there are no FDA-approved celiac disease therapies. The cornerstone of celiac disease management remains a strict, lifelong gluten-free diet, which is essential for alleviating symptoms, promoting intestinal healing, and preventing long-term complications. For patients experiencing celiac crisis or refractory celiac disease type II (RCD II), short-term use of corticosteroids like prednisolone may provide relief until the gluten-free diet becomes effective. Additional treatment options for both RCD I and RCD II include Budesonide, systemic corticosteroids, 6-mercaptopurine, cladribine, mesalamine, mycophenolate mofetil, and methotrexate.

Despite adherence to a gluten-free diet, approximately 5% of celiac disease patients continue to suffer from symptoms, underscoring the urgent need for advanced treatment options and further research. This significant unmet medical need has created substantial opportunities for pharmaceutical companies to develop innovative therapies that can address the limitations of current treatment approaches.

According to the DelveInsight report, the celiac disease therapies pipeline is robust and promising, with several novel treatments in late-stage development. Leading companies are focused on adopting a patient-centric approach to therapeutic trials, aiming to enhance patient involvement while ensuring scientific rigor in the development of new treatments.

Notable drugs in development include Latiglutenase from Entero Therapeutics (formerly First Wave BioPharma); TAK-101, TAK-227, and Zamaglutenase from Takeda, as well as PRV-015 (Provention Bio/Sanofi) and KAN-101 (Kanyos Bio/Anokion), among others. Each of these therapeutic candidates represents a different mechanistic approach to addressing the complex pathophysiology of celiac disease.

Therefore, the DelveInsight report shows that the celiac disease treatment market is highly competitive, with major players including Entero Therapeutics, Amgen/Provention Bio, Takeda, and Sanofi, all advancing a variety of therapies through robust R&D and strategic collaborations. These companies are at the forefront of improving the treatment landscape and developing more effective therapies for celiac disease, promising new hope for better management and outcomes.

The celiac disease treatment landscape has witnessed significant advancements in 2025, reflecting growing momentum toward alternatives to the traditionally restrictive gluten-free diet.

In May 2025, ZymagenX was launched as the successor to ImmunogenX to continue developing latiglutenase, now gearing up for a Phase III trial with active preparations in drug manufacturing and FDA protocol alignment. Around the same time, in May, Teva Pharmaceuticals received FDA Fast Track designation for TEV-53408, an anti-IL-15 monoclonal antibody aimed at reducing intestinal damage in patients on a gluten-free diet. Furthermore, Topas Therapeutics shared positive Phase IIa data for TPM502 at Digestive Disease Week in the same month, showing significant, dose-dependent immunomodulation of gluten-specific CD4+ T cells and symptom reduction following gluten challenge.

In March 2025, the FDA approved GlutenID, an over-the-counter genetic test that identifies individuals at risk for celiac disease. Anokion also contributed to the momentum with a January 2025 announcement of promising results from its Phase IIACeD-it trial of KAN-101, which demonstrated clinically meaningful symptom relief across multiple celiac-specific measures, marking the first symptomatic proof of concept for an immune tolerance therapy.

These developments collectively signal a shift toward more effective, immune-targeted therapies and improved patient screening tools in celiac disease care. Discover more recent advancements in the Celiac Disease treatment landscape @ Celiac Disease Recent Developments.

Looking ahead, the celiac disease market is expected to witness continued innovation driven by enhanced understanding of disease pathogenesis, which involves a complex interaction between genetic factors, particularly HLA-DQ2 and HLA-DQ8 haplotypes, and environmental triggers. The market growth is further supported by DelveInsight’s comprehensive qualitative analysis using SWOT analysis and conjoint analysis approaches, evaluating multiple approved and emerging therapies based on relevant attributes such as safety, efficacy, frequency of administration, route of administration, and order of entry.

As research continues and awareness grows, the celiac disease market is poised for remarkable expansion and therapeutic innovation in the coming decade.

Table of Contents

1. Key Insights

2. Report Introduction

3. Executive Summary of Celiac Disease

4. Key Events

5. Epidemiology and Celiac Disease Market Forecast Methodology

6. Celiac Disease Market Overview at a Glance

7. Celiac Disease Background and Overview

8. Celiac Disease Treatment and Management

9. Celiac Disease Epidemiology and Patient Population in the 7MM

10. Celiac Disease Patient Journey

11. Celiac Disease Marketed Therapies

12. Celiac Disease Emerging Therapies

13. Celiac Disease: Seven Major Market Analysis

14. Celiac Disease Unmet Needs

15. SWOT Analysis

16. KOL Views

17. Market Access and Reimbursement

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Celiac Disease Pipeline Insight

Celiac Disease Pipeline Insight provides comprehensive insights about the Celiac Disease pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Celiac Disease companies, including Sanofi, Entero Therapeutics, Takeda, Pfizer, Topas Therapeutics, Anokion SA, Protagonist Therapeutics, Equillium, AMYRA Biotech AG, Forte Biosciences, LAPIX Therapeutics, Ahead Therapeutics, Lumen Bioscience, and IGY Life Sciences, among others.

About DelveInsight

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Celiac Disease Treatment Market Set for Robust Growth Through 2034, Driven by Recent Developments in Clinical Development Pipeline | DelveInsight

FILM SNAP Launches New APP on iOS and Android

Los Angeles’ First Vertical-Drama App Combines Academy Craft, Global Distribution — and Funds a New NYFA Scholarship

LOS ANGELES – FILM SNAP, the mobile platform dedicated to 9:16 vertical short dramas and films, is now live worldwide on the Apple App Store and Google Play. Created by a Los Angeles–based team under Mimi Masters—Chief Executive Officer of IMC Film Production and alumna of the New York Film Academy (NYFA)—the app offers creators a one-stop path from upload to worldwide distribution and professional curation.

A First for L.A. FILM SNAP is the city’s first home-grown platform to fuse an academy-honed producing philosophy with Hollywood-level international distribution expertise, all supported by streaming-grade technology. This distinctive blend sets it apart from existing vertical-shorts services and anchors the venture firmly within Los Angeles’ creative ecosystem.

Vertical short dramas are one of the fastest-growing segments in screen entertainment, propelled by mobile-first, bite-size viewing habits. FILM SNAP’s in-house editorial team hand-picks standout submissions, ensuring emerging voices cut through the noise and reach audiences around the globe.

“FILM SNAP is designed to turn a smartphone into a theatrical launchpad,” said Mimi Masters. “By collapsing production, exhibition, and feedback into a single pipeline, we give new directors a direct route from concept to global audience.”

Andrzej Barkowiak, Academy Award–winning filmmaker and FILM SNAP’s Chief Recommending Officer, noted: “Fresh perspectives keep cinema alive. FILM SNAP hands those perspectives a runway straight from the phone screen to the world stage—exactly what the industry needs right now.”

Masters’ eight prior mobile-first projects—including The King’s Guard and the Influencer (2024) and Her Three Alphas (2025)—have already drawn online buzz and are being explored for future release on FILM SNAP.

Preliminary partnerships with film festivals, brand sponsors, and streaming outlets are already in place to provide investment and distribution opportunities for projects that gain traction on the app. “Our goal is to merge creative incubation, market validation, and commercial matchmaking in one ecosystem,” Masters added. “Great stories should never be limited by format or gatekeepers.”

Extending that commitment to opportunity, Masters has endowed an annual NYFA scholarship that fully funds MFA tuition for under-represented filmmakers. Davide Picci, the first recipient, graduated from NYFA’s Los Angeles campus this spring and is developing a debut short slated to premiere on FILM SNAP later this year. “This award turned an unlikely aspiration into a career,” Picci said. “It proves that our stories can travel far beyond our neighborhoods.”

Dr. Joy Zhu, NYFA’s Executive Vice President and senior academic leader in Los Angeles, praised the initiative: “Mimi’s model combines innovation with inclusion. By lowering financial barriers and opening a distribution pathway, she helps ensure the next generation of voices is as diverse as the audiences they hope to reach.”

Reflecting on her NYFA roots, Masters added, “The Academy taught me to point the camera toward the world I want to see. Supporting new filmmakers—through scholarships and through FILM SNAP—lets me hand that lens to the next generation.”

About FILM SNAP

FILM SNAP is a mobile platform for vertical short-form drama, offering creators global reach, algorithmic discovery, and professional mentorship. The app is available worldwide on the App Store and Google Play.

About the New York Film Academy

Founded in 1992, NYFA delivers intensive, hands-on film, media, and performing-arts programs on campuses in Los Angeles, New York, Miami, Florence, and online. Its alumni network spans narrative, documentary, television, and emerging digital formats.

Media Contact
Company Name: FILM SNAP
Contact Person: Landon Lee
Email: Send Email
City: Burbank
State: California
Country: United States
Website: https://film-snap.ca/

BizPower360 Named Exclusive Benefits and Technology Partner for Live Well USA

Nashville, TN – BizPower360 has partnered with Live Well USA, a national wellness association committed to improving the physical, mental, and financial health of Americans. As part of this strategic alliance, BizPower360 has been named the exclusive provider of insurance benefits for Live Well USA members through its proprietary BuzzOn Benefits platform.

This partnership also establishes BizPower360 as Live Well USA’s exclusive technology partner, driving digital infrastructure and integration that supports member engagement, enrollment, and benefit management through a unified, intelligent experience.

“Our relationship with Live Well USA reflects our commitment to empowering organizations with smart, scalable solutions,” said Tim Thomas, Chief Operating Officer of BizPower360. “Through BuzzOn Benefits and our technology services, we’re making it easier than ever for Live Well USA members to access valuable insurance coverage and wellness resources with speed, simplicity, and confidence.”

Under this partnership, Live Well USA members gain access to a curated portfolio of insurance products offered through the BuzzOn Benefits platform. BizPower360’s technology team has worked closely with Live Well USA leadership to implement a seamless digital experience that supports efficient onboarding, secure data management, and responsive service.

This partnership builds on BizPower360’s track record of delivering innovative employee benefit solutions and integrated technologies for organizations nationwide. By aligning with Live Well USA, BizPower360 expands its reach to a health-conscious, membership-driven audience committed to proactive well-being.

Media Contact
Company Name: BizPower360
Contact Person: Phil Milakovic
Email: Send Email
City: Nashville
State: Tennessee
Country: United States
Website: https://bizpower360.com

Eric Sakhnovsky’s Revival Contracting Co. Expands Roofing Services Across Northeast Ohio

Revival Contracting Co., a trusted name in residential roofing, siding, windows, and gutters, is quickly expanding its service footprint throughout Northeast Ohio. Under the leadership of Eric Sakhnovsky, the company is now bringing its customer-first roofing approach to Cleveland, Akron, and surrounding communities. Homeowners can get in touch here or view recent reviews and ratings on Google Maps to see why Revival is becoming the go-to roofing partner in the region.

Founded by Sakhnovsky after years of hands-on experience in both roofing labor and sales, Revival Contracting Co. was built with one clear mission: to deliver honest service and premium results—every time.

“We’re not trying to be the cheapest,” said Sakhnovsky. “We’re focused on quality and communication. People choose us because we actually show up, we answer the phone, and we do the job right.”

In a recent commercial flat-roof project, Revival went the extra mile—working around delicate machinery inside the building while adapting to extreme weather delays. Despite the job taking three weeks instead of the planned 10 days, the team completed it without a single leak or disruption to the client’s operations.

Revival Contracting Co. currently specializes in:

Residential Roofing
Siding, Gutter, and Window Installation
Skylight Repairs and Replacements
Storm Damage and Insurance Claims
Retail Roof Replacements Without Insurance

With new team members and sales reps expanding into Northeast Ohio, the company is scaling rapidly while maintaining the responsive customer service that drives its 5-star reviews.

One customer shared: “I hired Revival even though they were the most expensive quote I received. Eric’s responsiveness, honesty, and professionalism made all the difference. The quality was worth it.”

In a tightening insurance environment, Revival continues to support homeowners through detailed inspections, documentation, and its signature free Roof Health Reports—a smarter alternative to basic estimates.

“Our long-term goal is to be a household name,” Sakhnovsky added. “Even if you don’t need a roof today, we want you to remember us when that day comes.”

To schedule your free Roof Health Report, visit revivalcontractingco.com or reach out directly via revivalcontractingco.com/contact-us.

Media Contact
Company Name: Revival Contracting Co.
Contact Person: Eric Sakhnovsky
Email: Send Email
Phone: +1 330-737-2322
City: Youngstown
State: Ohio
Country: United States
Website: https://revivalcontractingco.com/

Mighty Dog Roofing of Tulsa Now Offers 24/7 Storm and Emergency Roofing Services in Midtown Tulsa

Mighty Dog Roofing of Tulsa announces its expanded 24/7 emergency roofing services in Midtown Tulsa, providing fast, reliable solutions for homeowners impacted by storm damage, hail, and wind-related roof issues.

Tulsa, OK – June 18, 2025 – Mighty Dog Roofing of Tulsa, a trusted name in residential and commercial roofing, is proud to announce the expansion of its storm and emergency roofing services to better serve homeowners in Midtown Tulsa. With Oklahoma’s unpredictable and often severe weather patterns, this initiative provides residents with a critical resource for fast, professional response and high-quality roof repair when disaster strikes.

“Mighty Dog Roofing understands the stress and disruption that storm damage can bring to a home,” said Drue Smallwood, Owner of Mighty Dog Roofing of Tulsa. “We’re committed to being there when our community needs us most—offering 24/7 emergency services and fast, high-quality repairs with the reliability and care our customers expect.”

The company’s emergency roofing response team is trained to handle the full scope of storm-related damages, including impacts from hail, high winds, fallen debris, and torrential rains. When homeowners are left vulnerable by roof leaks or missing shingles, Mighty Dog Roofing acts quickly to secure the property, limit interior damage, and begin the process of full restoration.

Services include:

Immediate response to storm and wind damage
Temporary tarping to prevent further interior damage
Detailed roof inspections using drone and satellite technology
Written storm damage reports for insurance purposes
Assistance with insurance claims and adjuster communications
Full-service repairs and roof replacements using premium materials

Midtown Tulsa, with its blend of historic homes and modern development, presents unique roofing challenges. Mighty Dog Roofing brings local knowledge and precision craftsmanship to each project, ensuring solutions that align with both the structural needs and aesthetic values of area homes.

In addition to emergency services, the company offers preventative maintenance plans and free annual inspections to help homeowners stay ahead of future issues. Their proactive approach is designed to catch minor problems before they become major expenses, especially during Oklahoma’s storm season.

Mighty Dog Roofing of Tulsa is fully licensed and insured, and their team undergoes continuous training to stay at the forefront of industry standards and technologies. Customer satisfaction is backed by warranties and a “Paw Prints” record tracking system, which provides a digital history of every roof for transparency and long-term maintenance planning.

“We take pride in being a dependable partner to our neighbors in Midtown,” said a spokesperson. “No matter the size of the storm or the scope of the damage, our team is ready to provide expert help when it’s needed most.”

For more information or to request emergency assistance, call (918) 212-5646 or visit their website.

Media Contact
Company Name: Mighty Dog Roofing of Tulsa
Contact Person: Drue Smallwood
Email: Send Email
Phone: (918) 212-5646
Address:8110 East 126th St S
City: Bixby
State: OK
Country: United States
Website: https://g.co/kgs/aWYhbHQ

New Biography “BIBS: Cabbages & Kings – Lady of the House” Honors Trailblazing Political Pioneer Elizabeth “Bibs” Metayer

A compelling new biography, BIBS: Cabbages & Kings – Lady of the House, pays tribute to the life and legacy of Elizabeth “Bibs” Metayer, Braintree’s first female State Representative and a fearless advocate for public service, women’s rights, and community leadership. Authored by Byrne Laurence Corbin, the book has already garnered critical acclaim and is the recipient of the Literary Titan Book Award.

Through a vibrant blend of storytelling, personal reflections, historical insight, and the late Representative Metayer’s own poetic voice, Corbin presents an intimate portrait of a woman whose influence continues to shape Massachusetts politics. From her remarkable election to the Massachusetts House of Representatives at the age of 62 to her decades-long commitment to fiscal reform, consumer protection, environmental conservation, and tax relief, Metayer’s story is one of determination, wit, and unwavering purpose.

The biography not only charts her professional accomplishments but also delves into the heart of the woman behind the podium, highlighting her magnetic personality, her passion for civic engagement, and her role in shattering gender barriers in government. In addition to Elizabeth’s original writings, the book features heartfelt tributes and speeches from peers and close friends, further enriching the narrative.

BIBS: Cabbages & Kings – Lady of the House has been described by Literary Titan as “a beautifully crafted homage to a woman who lived a life full of purpose and passion.” The review praises Corbin’s ability to “seamlessly blend Elizabeth’s personal writings with his own narrative voice,” calling the book “engaging and intimate… a great read for anyone interested in women’s history, public service, or simply looking for an inspiring story of a life well-lived.”

This literary tribute is more than a biography—it is a powerful reminder of how one woman’s courage and conviction can break boundaries and pave the way for future generations.

Don’t miss the chance to discover the inspiring story of a true political trailblazer. BIBS: Cabbages & Kings – Lady of the House is available now in hardcover, paperback, and eBook formats. Experience the life and legacy of Elizabeth “Bibs” Metayer—order your copy today on Amazon or Barnes & Noble and be moved by the heartfelt journey of a woman who changed the face of local politics and left an enduring mark on her community.

About the Author

Byrne Laurence Corbin was born in Quincy, Massachusetts, and raised in Braintree as the middle of three boys. With a foundation in parochial education that emphasized both intellectual and spiritual development, Corbin cultivated a deep appreciation for service, heritage, and storytelling. His professional background spans over 25 years in the construction industry, where he has worked extensively with architects and contractors throughout New England and South Florida.

Inspired by his late grandmother’s dream of writing a book, Corbin brings a heartfelt personal connection to this project—his first major literary endeavor. His passion for history, writing, and photography is rooted in a profound respect for the individuals who shaped his life and community. Now based in Florida, Corbin is a devoted husband and father who continues to contribute meaningfully to both the business and literary landscapes.

To learn more about author Byrne Laurence Corbin, explore his latest works, and watch the captivating trailer for BIBS: Cabbages & Kings – Lady of the House, visit his official website bibslegacy.com.

Media Contact
Company Name: New Age Literary Agency
Contact Person: Byrne Corbin
Email: Send Email
Country: United States
Website: https://bibslegacy.com/